enVVeno Medical Corp reports results for the quarter ended in December - Earnings Summary

enVVeno Medical

29/02/2024 23:45

* enVVeno Medical Corp  NVNO.OQ  reported a quarterly
adjusted
loss of 36 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -55 cents.  The lone analyst forecast for the
quarter was for a loss of 46 cents per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * enVVeno Medical Corp's reported EPS for the quarter was a
loss
of 36 cents​.
    * The company reported a quarterly loss of $5.65 million.
    * enVVeno Medical Corp shares had risen by 29.4% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for enVVeno Medical
Corp is $20.40 
This summary was machine generated from LSEG data February 29 at
11:45 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.46          -0.36          Beat
 Sep. 30 2023      -0.48          -0.45          Beat
 Jun. 30 2023      -0.49          -0.58          Missed
 Mar. 31 2023      -0.48          -0.57          Missed